References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Brownetal(2001)IdentificationofasubtypeselectivehumanPPARαagonistthroughparallel-arraysynthesis.Bioorg.Med.Chem.Lett.111225PMID:11354382
Cunardetal(2002)Regulationofcytokineexpressionbyligandsofperoxisomeproliferatoractivatedreceptors.J.Immunol.1682795PMID:11884448
Muoioetal(2002)Peroxisomeproliferator-activatedreceptor-αregulatesfattyacidutilizationinprimaryhumanskeletalmusclecells.Diabetes51901PMID:11916905
Paukkerietal(2007)PPARalphaagonistsinhibitnitricoxideproductionbyenhancingiNOSdegradationinLPS-treatedmacrophages.Br.J.Pharmacol.1521081PMID:17891158
Keywords:GW7647,supplier,selective,potent,PPARα,PPARalpha,agonists,Orally,active,Peroxisome,Proliferator-activating,Receptors,PPAR,GW7647,GlaxoSmithKline,GSK,anti-inflammatory,PPARalpha,Receptors,PPARalpha,Receptors,TocrisBioscience